Hoge Stephen's Form 4 filing
Moderna, Inc.MRNA · filed Nov 18, 2026
- Accession no.
- 0001682852-26-000210
- Filed
- Nov 18, 2026, 4:36 PM ET
- Trade date
- Nov 16-17, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $16.9M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoge StephenCIK 0001760669 | Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | MOption exerciseAcquired | +76,453 | $12.21 | +$933,491.13 | 1,713,018 | Direct | |
| Nov 16, 2026 | Common Stock | SSaleDisposed | −39,160 | $219.66F2 | −$8,601,885.6 | 1,673,858 | Direct | |
| Nov 16, 2026 | Common Stock | GGiftDisposed | −400,000 | $0.00F3 | $0 | 1,273,858 | Direct | |
| Nov 17, 2026 | Common Stock | MOption exerciseAcquired | +76,452 | $12.21 | +$933,478.92 | 1,350,310 | Direct | |
| Nov 17, 2026 | Common Stock | SSaleDisposed | −33,976 | $211.45F4 | −$7,184,225.2 | 1,316,334 | Direct | |
| Nov 17, 2026 | Common Stock | SSaleDisposed | −5,082 | $212.57F5 | −$1,080,280.74 | 1,311,252 | Direct | |
| Nov 17, 2026 | Common Stock | SSaleDisposed | −157 | $214.19F6 | −$33,627.83 | 1,311,095 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | MOption exerciseDisposed | −76,453 | $0.00 | $0 | 76,452 | Direct | |
| Nov 17, 2026 | Common Stock | MOption exerciseDisposed | −76,452 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $219.54 to $220.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The reported disposition represents a bona fide charitable gift made by the reporting person.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $211.41 to $212.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $212.50 to $213.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $213.92 to $214.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.